Sec Form 4 Filing - Madan Jay P. @ INNOVATE BIOPHARMACEUTICALS, INC. - 2019-05-30

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Madan Jay P.
2. Issuer Name and Ticker or Trading Symbol
INNOVATE BIOPHARMACEUTICALS, INC. [ INNT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President
(Last) (First) (Middle)
C/O INNOVATE BIOPHARMACEUTICALS, INC.,, 8480 HONEYCUTT ROAD, SUITE 120
3. Date of Earliest Transaction (MM/DD/YY)
05/30/2019
(Street)
RALEIGH, NC27615
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common stock 05/30/2019 P 5,000 A $ 1.32 84,131 D
Common stock 129,593 I ( 1 ) By Madan Global, Inc.
Common stock 122,104 I ( 2 ) By OM Healthcare Partners LLC
Common stock 122,104 I ( 3 ) By OM Healthcare Partners II LLC
Common stock 122,104 I ( 4 ) By OM Healthcare Partners III LLC
Common stock 450,000 I ( 5 ) By MGI Holdings II LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Madan Jay P.
C/O INNOVATE BIOPHARMACEUTICALS, INC.,
8480 HONEYCUTT ROAD, SUITE 120
RALEIGH, NC27615
X President
Signatures
/s/ Kendyle Woodard, as Attorney-in-Fact 06/03/2019
Signature of Reporting Person Date
Explanation of Responses:
( 1 )These shares are held by Madan Global, Inc. Mr. Madan is the sole owner of Madan Global, Inc. and has voting and investment power over the shares held by Madan Global, Inc.
( 2 )These shares are held by OM Healthcare Partners LLC. Mr. Madan is the sole owner and manager of OM Healthcare Partners LLC and has voting and investment power over the shares held by OM Healthcare Partners LLC.
( 3 )These shares are held by OM Healthcare Partners II LLC. Mr. Madan is the sole owner and manager of OM Healthcare Partners II LLC and has voting and investment power over the shares held by OM Healthcare Partners II LLC.
( 4 )These shares are held by OM Healthcare Partners III LLC. Mr. Madan is the sole owner and manager of OM Healthcare Partners III LLC and has voting and investment power over the shares held by OM Healthcare Partners III LLC.
( 5 )These shares are held by MGI Holdings II LLC. Mr. Madan is the sole owner and manager of MGI Holdings II LLC and has voting and investment power over the shares held by MGI Holdings II LLC.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.